Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study
1 other identifier
observational
40
1 country
1
Brief Summary
Evaluation of apgar, hemogram and developmental status of babies born from covid 19 positive mothers
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2020
CompletedFirst Submitted
Initial submission to the registry
April 5, 2020
CompletedFirst Posted
Study publicly available on registry
April 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 25, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2020
CompletedJune 11, 2020
June 1, 2020
2 months
April 5, 2020
June 9, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Evaluation of apgar status of newborns from covid 19 positive mothers
The Apgar score is looked after at 1 and 5 minutes after birth, if the baby's Apgar score is lower than 7, it is repeated every 5 minutes until 20 minutes. Parameters examined in Apgar score Muscle tone, Heart rate, Reflexes, Skin color, Respiration. In the Apgar score, the baby is evaluated and scores are collected. 7 - 10: The baby is normal. 4 - 6: They usually recover with respiratory support. 0 - 3: Urgent intervention and resuscitation is needed. The low Apgar score in the 1st minute usually returns to normal in the 5th minute with support. Despite the intervention, the Apgar scores of 5 and less at 5 and 10 minutes are associated with an increased risk of mortality and cerebral palsy.
2 months
Interventions
Evaluation of apgar, hemogram and developmental status of babies born from covid 19 positive mothers
Eligibility Criteria
Evaluation of apgar, hemogram and developmental status of babies born from covid 19 positive mothers
You may qualify if:
- from covid 19 positive mothers
- newborn mothers had not other condition or illness
You may not qualify if:
- from covid 19 negative mothers
- childs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, 34000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 5, 2020
First Posted
April 7, 2020
Study Start
March 15, 2020
Primary Completion
May 25, 2020
Study Completion
May 30, 2020
Last Updated
June 11, 2020
Record last verified: 2020-06